HiGlance

Pharmaceutical production and export of medicines for various health issues from India.

About HiGlance

HiGlance is a Healthcare company. Pharmaceutical production and export of medicines for various health issues from India. The company has 386 employees. Its Indian entity Higlance Laboratories Private Limited reported revenue of β‚Ή75.98 Cr. HiGlance offers products and services including Pharmaceutical Products and Contract Manufacturing. Its focus areas include Pharmaceuticals, Drug Manufacturing, Antibiotic Production and Research and Development.

Company details

HiGlance is recognized as a leading producer and exporter of pharmaceutical products, with a wide range of medicines developed for treating infections, allergies, and metabolic disorders. The companys quality systems are certified under ISO 9001-2008, GMP, and WHO GMP, and products are aligned with international pharmacopeia standards. Participation in WHO programs for combating diseases is noted, while exports are facilitated through automated systems and representations in multiple countries. Information on the site is intended for specialists only.

  • Employees 386
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website higlance.ru
  • Legal Name Higlance Laboratories Pvt. Ltd
  • Date of Incorporation 11 Jun, 2003
  • Jurisdiction New Delhi, Delhi, India
Key Metrics
  • Indian entity revenue
    ₹75.98 Cr

    FY 2025 · +7% YoY

  • Indian entity net profit
    ₹6.26 Cr

    FY 2025 · 8% margin

  • Indian entity EBITDA
    ₹11.94 Cr

    FY 2025 · 16% margin

  • Employee Count
    386

Products & Services of HiGlance

HiGlance offers a comprehensive portfolio of products and services, including Pharmaceutical Products and Contract Manufacturing.

Pharmaceutical Products
Medications

Products for treating infections and other health conditions are manufactured and supplied by HiGlance

Contract Manufacturing
Production Services

Services for pharmaceutical production are provided by HiGlance to meet external demands

Board of directors of Higlance Laboratories Private Limited (HiGlance)

Higlance Laboratories Private Limited is the primary company behind HiGlance. The board of Higlance Laboratories Private Limited currently have 3 directors; the longest-serving is Kalawati Devi, appointed in 2003. 5 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Kalawati Devi
DIN 01657491
Director11 Jun 200323 yrs 5 moHiglance Laboratories Private Limited
Ajay Singh
DIN 01048028
Whole-time director11 Jun 200323 yrs 5 moHiglance Laboratories Private Limited
Sanjay Kumar Singh
DIN 01598183
Managing Director11 Jun 200323 yrs 5 moHiglance Laboratories Private Limited

Financials of HiGlance

Figures of Higlance Laboratories Private Limited, the primary company behind HiGlance, for FY 2025. Revenue was ₹75.98 Cr (+7% year on year). Net profit was ₹6.26 Cr (8% margin). EBITDA was ₹11.94 Cr (16% margin). Revenue has grown at a compounded annual rate of +8% over three years and +11% over five years.

  • ₹75.98 CrRevenue · FY 2025 · +7% YoY
  • ₹6.26 CrNet profit · 8% margin
  • ₹11.94 CrEBITDA · 16% margin
  • ₹6.00 CrPaid-up capital
  • 386Employees (provident fund records)
  • +8%Revenue CAGR, 3 years
  • +11%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Higlance Laboratories Private Limited are on its company page.

Premium access

Detailed financial statements for HiGlance

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about HiGlance

HiGlance has 386 employees.

The primary company behind HiGlance, Higlance Laboratories Private Limited, reported revenue of β‚Ή75.98 Cr for FY 2025, up 7% year on year.

HiGlance is recognized as a leading producer and exporter of pharmaceutical products, with a wide range of medicines developed for treating infections, allergies, and metabolic disorders. The companys quality systems are certified under ISO 9001-2008, GMP, and WHO GMP, and products are aligned with international pharmacopeia standards. Participation in WHO programs for combating diseases is noted, while exports are facilitated through automated systems and representations in multiple countries. Information on the site is intended for specialists only.

HiGlance offers Pharmaceutical Products and Contract Manufacturing.

HiGlance operates through Higlance Laboratories Private Limited.

The legal entities of HiGlance currently have 3 directors, including Kalawati Devi, Ajay Singh, Sanjay Kumar Singh.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available